Filing Details
- Accession Number:
- 0001209191-18-013864
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-27 16:12:07
- Reporting Period:
- 2018-02-23
- Accepted Time:
- 2018-02-27 16:12:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 917520 | Integra Lifesciences Holdings Corp | IART | Laboratory Analytical Instruments (3826) | 510317849 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1188650 | Keith Bradley | 311 C Enterprise Dr Plainsboro NJ 08536 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-02-23 | 40 | $54.07 | 37,074 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2018-02-23 | 9 | $54.07 | 37,065 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2018-02-26 | 15,658 | $18.06 | 52,723 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-26 | 15,658 | $55.00 | 37,065 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2018-02-26 | 15,658 | $0.00 | 15,658 | $18.06 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-05-19 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- The price shown above represents the weighted average price of the shares sold. The range of sale prices was $55 to $55.02.
- 25% of the stock options vest every quarter from the grant date of 5/19/2010.
- This option was previously reported as covering 7,500 shares at an exercise price of $41.75 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 7,829 shares of common stock at an exercise price of $36.12 per share.
- In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.
Billionaire Hedge Funds
